BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Molecular Devices Ltd (MDCC) Introduces ScanLater Western Blot Detection System


10/16/2013 8:58:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sunnyvale, California, October 16 2013 – Molecular Devices announced today the launch of the ScanLater™ Western Blot Detection System. The first of its kind system combines western blot membrane detection with a multimode microplate reader platform, eliminating the need to acquire a separate dedicated western blot system, saving both lab space and budget. The system is compatible with Molecular Devices’ SpectraMax® i3 and SpectraMax Paradigm® Platforms.

ScanLater System is a time-resolved fluorescence (TRF)-based western blot detection assay, an optimal detection method that reduces stray excitation light, resulting in lower background noise and higher sensitivity. The ScanLater System comprises the ScanLater Western Blot Detection Cartridge, ScanLater Western Blot Kit and image acquisition software powered by SoftMax Pro® Software. ScanLater Western Blot Kits contain europium-labeled secondary antibodies designed to work with existing primary antibodies without further optimization. This substrate-free method of western blot detection not only outperforms traditional chemiluminescence and fluorescence-based western blot detection, it also allows membrane detection at any time.

Users can add western blot detection capability to the SpectraMax i3 or SpectraMax Paradigm Platform in just minutes by installing the ScanLater Western Blot Detection Cartridge. The cartridge is driven by SoftMax Pro Software, enabling users to run both microplate-based assays and western blot membrane detection from one software platform. SoftMax Pro Software provides a simple interface for acquiring .tif based images which may be printed, saved or exported to third party analysis packages. Using an add-on for ImageJ in SoftMax Pro Software, ScanLater System images are seamlessly exported with a single click.

Kevin Chance, President at Molecular Devices, commented: “Molecular Devices is committed to developing novel applications for our microplate customers, offering them the widest range of utility possible. The addition of the ScanLater Western Blot Detection System follows the introduction of the MiniMax Imaging Cytometer earlier this year, with the SpectraMax i3 System now leading the market in terms of application breadth.”

For more information please visit: www.moleculardevices.com/westernblot

For high resolution image please email sarah.jeffery@zymecommunications.com

Contacts

Media contact:

Sarah Jeffery

Zyme Communications

T: +44 7771 730 919

E: sarah.jeffery@zymecommunications.com

Twitter: zymecomms

At Molecular Devices

Jennifer McKie

Vice President, Global Marketing

E: jennifer.mckie@moldev.com

T: +1 408 747 3514

About Molecular Devices, LLC

Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.

Molecular Devices is committed to the continual development of innovative solutions for life science applications. The Company is headquartered in Silicon Valley with offices around the globe.

For more information about the complete product portfolio, visit www.moleculardevices.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES